ADVERTISEMENT
ADVERTISEMENT
EXCLUSIVE
Colorful pills and capsules on a calendar background
Clinical Trial Registry Errors Undermine Transparency
A lack of comprehension among some researchers about how to use ClinicalTrials.gov may be hindering public access to trial information and holding up drug study results, an investigation by The Scientist finds.
Clinical Trial Registry Errors Undermine Transparency
Clinical Trial Registry Errors Undermine Transparency

A lack of comprehension among some researchers about how to use ClinicalTrials.gov may be hindering public access to trial information and holding up drug study results, an investigation by The Scientist finds.

A lack of comprehension among some researchers about how to use ClinicalTrials.gov may be hindering public access to trial information and holding up drug study results, an investigation by The Scientist finds.

result reporting
Doctor holding stethoscope in front of European Union flag
New EU Protocol Aims to Improve Clinical Trial Transparency
Sophie Fessl, PhD | Feb 16, 2022 | 4 min read
A new regulation and registry covering investigational medicinal products mandates reporting and supports multinational trials.
About Half of Clinical Trials Go Unreported in EU
Sukanya Charuchandra | Sep 14, 2018 | 2 min read
Pharma companies are more compliant in posting results compared to universities.
New Automated Tool Monitors Clinical Trial Reporting
Diana Kwon | Feb 21, 2018 | 3 min read
The watchdog website FDAAA TrialsTracker names and shames human studies that breach the FDA’s requirements for reporting results.
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Diana Kwon | Dec 4, 2017 | 4 min read
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.
Stem Cell Trial Data Mostly Go Unpublished
Anna Azvolinsky | May 5, 2017 | 4 min read
Less than half of completed stem cell studies in humans are published in peer-reviewed journals, according to an analysis of regenerative medicine trials. 
Feds Demand More Clinical Trial Reporting
Kerry Grens | Sep 19, 2016 | 2 min read
Expanded US Health and Human Services rules will require the results of more human studies to be made public.
Legislating Negative Result Reporting
Bob Grant | May 7, 2012 | 1 min read
A new bill aims to increase transparency in cancer clinical trials by requiring researchers to divulge all outcomes.
ADVERTISEMENT